Wang Jing-Hua, Bose Shambhunath, Lim Soo-Kyoung, Ansari AbuZar, Chin Young-Won, Choi Han Seok, Kim Hojun
Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, 814 Siksa, Goyang 10326, Gyeonggi-do, Korea.
NosQuest, USPACE 1A-1103, Daewang Pangyoro 660, Bundang-gu, Seongnam-si 13494, Gyeonggi-do, Korea.
Genes (Basel). 2017 Sep 22;8(10):239. doi: 10.3390/genes8100239.
Metformin and are representative anti-diabetic therapeutics in western and oriental medicine, respectively. The current study examined the synergistic anti-diabetic effect of extraction (HCE) and metformin combination in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Fecal microbiota were analyzed by denaturing gradient gel electrophoresis (DGGE) and real-time PCR. Combining HCE + metformin resulted in significantly ameliorated glucose tolerance (oral glucose tolerance test (OGTT))-the same as metformin alone. Particularly, results of the insulin tolerance test (ITT) showed that combining HCE + metformin dramatically improved insulin sensitivity as compared to metformin treatment alone. Both fecal and serum endotoxin, as well as cytokines (tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6)) were significantly ameliorated by HCE + metformin compared to metformin alone. Meanwhile, the activation of AMPK (adenosine monophosphate-activated protein kinase) by metformin was distinctly enhanced by HCE. Both of HCE and metformin evidently changed the gut microbiota composition, causing the alteration of bacterial metabolite, like short-chain fatty acids. , together with metformin, exerts intensive sensibilization to insulin; the corresponding mechanisms are associated with alleviation of endotoxemia via regulation of gut microbiota, particularly , , and Gram-negative bacterium.
二甲双胍和[未提及的药物名称]分别是西方医学和东方医学中具有代表性的抗糖尿病疗法。本研究检测了[未提及的药物名称]提取物(HCE)与二甲双胍联合使用对大冢长- Evans 德岛肥胖(OLETF)大鼠的协同抗糖尿病作用。通过变性梯度凝胶电泳(DGGE)和实时聚合酶链反应(PCR)分析粪便微生物群。联合使用HCE + 二甲双胍可显著改善葡萄糖耐量(口服葡萄糖耐量试验(OGTT)),与单独使用二甲双胍的效果相同。特别是,胰岛素耐量试验(ITT)结果显示,与单独使用二甲双胍治疗相比,联合使用HCE + 二甲双胍可显著提高胰岛素敏感性。与单独使用二甲双胍相比,HCE + 二甲双胍可显著改善粪便和血清内毒素以及细胞因子(肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6))水平。同时,HCE可显著增强二甲双胍对腺苷单磷酸激活的蛋白激酶(AMPK)的激活作用。HCE和二甲双胍均明显改变了肠道微生物群组成,导致细菌代谢产物如短链脂肪酸的改变。[未提及的药物名称]与二甲双胍一起对胰岛素产生强烈的增敏作用;相应机制与通过调节肠道微生物群,特别是[未提及的微生物名称]、[未提及的微生物名称]和革兰氏阴性菌来减轻内毒素血症有关。